About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
High-Intensity Statin Therapy
- Company
- Taipei Medical University Hospital
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 6 recruiting
Efficacy results: Not yet reported
6 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 18, 2026
Find a Clinical Trial Near Me
See recruiting studies for High-Intensity Statin Therapy and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT06676280
ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Not yet reported Jung-min Ahn 5000 participants Est. completion 2035-12-31 32 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT06767774
Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus
Not yet reported Korea University Anam Hospital 2000 participants Est. completion 2030-01-31 1 siteCardiovascular disease Other conditions: Diabetes, StatinView official trial listing → -
Recruiting NCT NCT07012629
A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)
Not yet reported Aarhus University Hospital 1652 participants Est. completion 2040-01-01 14 sites Stand-aloneOther conditions: Covert Brain InfarctionView official trial listing → -
Recruiting NCT NCT07586540
Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque
Not yet reported Middle East North Africa Stroke and Interventional Neurotherapies Organization 280 participants Est. completion 2030-09 15 sites Stand-aloneOther conditions: Carotid StenosisView official trial listing → -
Recruiting NCT NCT07611747
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
Not yet reported Instituto de Investigación Marqués de Valdecilla 1944 participants Est. completion 2031-12 17 sites Stand-aloneOther conditions: Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Systemic Lupus Erythematosus (SLE), Carotid Artery Diseases, Cardio Vascular Disease, Atheroscleroses, Axial SpondyloarthritisView official trial listing → -
Recruiting NCT NCT07824323
Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome
Not yet reported Taipei Medical University Hospital 400 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: Acute Coronary Syndromes, DyslipidemiaView official trial listing → -
Status unknown NCT NCT02579499
Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease
Not yet reported Yonsei University 4400 participants Est. completion 2022-11 1 siteOther conditions: Coronary Artery DiseasseView official trial listing → -
Completed NCT NCT02586155
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
Not yet reported Resverlogix Corp 2425 participants Est. completion 2021-06-21 214 sites Stand-aloneType 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT04753606
Randomized Study of Obicetrapib as an Adjunct to Statin Therapy
Not yet reported NewAmsterdam Pharma 120 participants Est. completion 2021-08-30 19 sitesOther conditions: Dyslipidemias, High Cholesterol, HypercholesterolemiaView official trial listing → -
Completed NCT NCT05166187
Best Practice Advisory to Initiate High-Intensity Statin Therapy in Patients With Peripheral Artery Disease
Not yet reported Vanderbilt University Medical Center 152 participants Est. completion 2023-11-13 1 siteOther conditions: Peripheral Artery DiseaseView official trial listing → -
Completed NCT NCT05266586
Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy
Not yet reported NewAmsterdam Pharma 119 participants Est. completion 2022-09-08 16 sitesOther conditions: Dyslipidemias, High Cholesterol, HypercholesterolemiaView official trial listing → -
Completed NCT NCT05306990
Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome
Not yet reported Helwan University 108 participants Est. completion 2021-01-31 1 siteOther conditions: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes MellitusView official trial listing → -
Active, not recruiting NCT NCT05457582
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
Not yet reported Nanjing First Hospital, Nanjing Medical University 1212 participants Est. completion 2030-12-30 1 siteOther conditions: Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention, Cardiovascular EventsView official trial listing → -
Enrolling by invitation NCT NCT05579626
Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)
Not yet reported Seung-Whan Lee, M.D., Ph.D. 4000 participants Est. completion 2030-12-31 31 sitesCardiovascular disease Other conditions: Pre DiabetesView official trial listing → -
Completed NCT NCT05806723
Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
Not yet reported Hopital La Rabta 104 participants Est. completion 2022-09-15 1 siteType 2 diabetes Other conditions: Dyslipidemia Associated With Type II Diabetes Mellitus, Statin Adverse Reaction, Hypogonadism, Male, Adrenal Insufficiency, Vitamin D DeficiencyView official trial listing → -
Active, not recruiting NCT NCT06238466
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia
Not yet reported AstraZeneca 98 participants Est. completion 2027-04-08 5 sitesOther conditions: CardiovascularView official trial listing → -
Not yet recruiting NCT NCT07432516
Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial
Not yet reported Yonsei University 4400 participants Est. completion 2033-06 1 siteCardiovascular diseaseView official trial listing → -
Not yet recruiting NCT NCT07799779
Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome
Not yet reported Seoul National University Bundang Hospital 294 participants Est. completion 2029-09 1 site Stand-aloneOther conditions: Acute Coronary Syndromes (ACS)View official trial listing → -
Completed NCT NCT07937709
CAROTID STABILISE Pilot: Alirocumab for Symptomatic Carotid Stenosis
Not yet reported Middle East North Africa Stroke and Interventional Neurotherapies Organization 40 participants Est. completion 2026-08-26 5 sitesOther conditions: Carotid Artery StenosisView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
